Oscotec Inc banner
O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 54 400 KRW 0.18% Market Closed
Market Cap: ₩2.1T

Gross Margin

91.4%
Current
Improving
by 16.2%
vs 3-y average of 75.2%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
91.4%
=
Gross Profit
₩21.2B
/
Revenue
₩23.2B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
91.4%
=
Gross Profit
₩21.2B
/
Revenue
₩23.2B

Peer Comparison

Country Company Market Cap Gross
Margin
KR
Oscotec Inc
KOSDAQ:039200
2.1T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
959.3B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
292.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
242.3B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
305.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
151.4B USD
Loading...
UK
GSK plc
XETRA:GS71
103.2B EUR
Loading...

Market Distribution

Higher than 97% of companies in Korea
Percentile
97th
Based on 2 511 companies
97th percentile
91.4%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

Oscotec Inc
Glance View

Market Cap
2.1T KRW
Industry
Pharmaceuticals

Oscotec, Inc. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2007-01-17. The firm operates its business through three divisions: new medicines division, functional material products division and dental bone graft division. Its new medicines division provides osteoporosis drugs, arthritis drugs and periodontal disease drugs. Its functional material products division provides functional materials and food used for promoting bone growth and periodontal health. Its dental bone graft division provides bone graft materials, membranes and centrifuges. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
102 278.58 KRW
Undervaluation 47%
Intrinsic Value
Price
O
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
91.4%
=
Gross Profit
₩21.2B
/
Revenue
₩23.2B
What is Oscotec Inc's current Gross Margin?

The current Gross Margin for Oscotec Inc is 91.4%, which is above its 3-year median of 75.2%.

How has Gross Margin changed over time?

Over the last 3 years, Oscotec Inc’s Gross Margin has increased from 59.6% to 91.4%. During this period, it reached a low of 55.9% on Jun 30, 2024 and a high of 95.1% on Jun 30, 2025.

Back to Top